These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31074492)

  • 1. Prescription patterns of lipid lowering agents among older patients in general practice: an analysis from a national database in the Netherlands.
    Kleipool EEF; Nielen MMJ; Korevaar JC; Harskamp RE; Smulders YM; Serné E; Thijs A; Peters MJL; Muller M
    Age Ageing; 2019 Jul; 48(4):577-582. PubMed ID: 31074492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
    van Peet PG; Gussekloo J; den Elzen WP; Blom JW; de Waal MW; de Ruijter W
    Scand J Prim Health Care; 2015; 33(4):260-8. PubMed ID: 26683286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.
    Wu J; Zhu S; Yao GL; Mohammed MA; Marshall T
    PLoS One; 2013; 8(7):e67611. PubMed ID: 23922649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993-1998) in a Danish population.
    Larsen J; Andersen M; Kragstrup J; Gram LF
    Eur J Clin Pharmacol; 2001 Jul; 57(4):343-8. PubMed ID: 11549214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.
    Simmons RK; Carlsen AH; Griffin SJ; Charles M; Christiansen JS; Borch-Johnsen K; Sandbaek A; Lauritzen T
    Diabet Med; 2014 Dec; 31(12):1577-85. PubMed ID: 25185778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-prescription patterns of cardiovascular preventive treatments: a cross-sectional study in the Aragon worker' health study (Spain).
    Aguilar-Palacio I; Malo S; Lallana M; Feja C; González J; Moreno-Franco B; Rabanaque M
    BMJ Open; 2019 Apr; 9(4):e023571. PubMed ID: 30987984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients.
    Franchi C; Lancellotti G; Bertolotti M; Di Salvatore S; Nobili A; Mannucci PM; Mussi C; Ardoino I;
    Clin Interv Aging; 2021; 16():1251-1264. PubMed ID: 34239298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes.
    Charles MH; Thomsen JL; Christensen B; Pulleyblank R; Kongstad LP; Olsen KR
    Diabetologia; 2022 Feb; 65(2):286-290. PubMed ID: 34709425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark.
    Graversen L; Christensen B; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Scand J Prim Health Care; 2010 Mar; 28(1):47-54. PubMed ID: 19929180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does shared decision-making reduce antibiotic prescribing in primary care?
    van Esch TEM; Brabers AEM; Hek K; van Dijk L; Verheij RA; de Jong JD
    J Antimicrob Chemother; 2018 Nov; 73(11):3199-3205. PubMed ID: 30165644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices.
    Cho YY; Sidorenkov G; Denig P
    PLoS One; 2016; 11(11):e0166012. PubMed ID: 27806107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication prescribing in frail older people.
    Hubbard RE; O'Mahony MS; Woodhouse KW
    Eur J Clin Pharmacol; 2013 Mar; 69(3):319-26. PubMed ID: 22965651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromso study 2001.
    Hartz I; Eggen AE; Grimsgaard S; Skjold F; Njølstad I
    Eur J Clin Pharmacol; 2004 Nov; 60(9):643-9. PubMed ID: 15455181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics.
    Yang CC; Jick SS; Testa MA
    Br J Clin Pharmacol; 2003 Jul; 56(1):84-91. PubMed ID: 12848779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increase in opioid prescribing in extramural care in the Netherlands: assessment of use and prescription behaviour, based on claims data].
    Schepens MHJ; Leusink M; de Vries SE; van Erkelens JA; Eleveld H; Prenger A; van Limbeek J; Berger MY
    Ned Tijdschr Geneeskd; 2019 Apr; 163():. PubMed ID: 31050276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What proportion of initially prescribed antidepressants is still being prescribed chronically after 5 years in general practice? A longitudinal cohort analysis.
    Verhaak PFM; de Beurs D; Spreeuwenberg P
    BMJ Open; 2019 Feb; 9(2):e024051. PubMed ID: 30813115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy.
    Larsen J; Vaccheri A; Andersen M; Montanaro N; Bergman U
    Br J Clin Pharmacol; 2000 May; 49(5):463-71. PubMed ID: 10792204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Age, Multimorbidity and Frailty on the Prescription of Preventive Antiplatelet Therapy in Older Population.
    Laborde C; Barben J; Mihai AM; Nuss V; Vovelle J; d'Athis P; Jouanny P; Putot A; Manckoundia P
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32599756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trial.
    Luymes CH; Poortvliet RKE; van Geloven N; de Waal MWM; Drewes YM; Blom JW; Smidt N; Assendelft WJJ; van den Hout WB; de Ruijter W; Numans ME
    BMC Med; 2018 Jan; 16(1):5. PubMed ID: 29321031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners' prescribing of lipid-lowering medications for Indigenous and non-Indigenous Australians, 2001-2013.
    Trivedi AN; Pollack AJ; Britt HC; Miller GC; Harrison C; Kelaher MA
    Med J Aust; 2015 Nov; 203(10):407-7.e5. PubMed ID: 26561906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.